Literature DB >> 28220542

The gut microbiome in human neurological disease: A review.

Helen Tremlett1, Kylynda C Bauer2,3, Silke Appel-Cresswell1,4, Brett B Finlay2,3, Emmanuelle Waubant5.   

Abstract

Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data libraries, and application of high-throughput sequencing have allowed these microbes to be identified and their contribution to neurological health to be examined. Emerging evidence links perturbations in the gut microbiota to neurological disease, including disease risk, activity, and progression. This review provides an overview of the recent advances in microbiome research in relation to neuro(auto)immune and neurodegenerative conditions affecting humans, such as multiple sclerosis, neuromyelitis optica spectrum disorders, Parkinson disease, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis. Study design and terminology used in this rapidly evolving, highly multidisciplinary field are summarized to empower and engage the neurology community in this "newly discovered organ." Ann Neurol 2017;81:369-382.
© 2017 American Neurological Association.

Entities:  

Mesh:

Year:  2017        PMID: 28220542     DOI: 10.1002/ana.24901

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  138 in total

1.  Fecal microbiota transplantation from patients with autoimmune encephalitis modulates Th17 response and relevant behaviors in mice.

Authors:  Hao Chen; Zhaoyu Chen; Liping Shen; Xiuhua Wu; Xueying Ma; Dengna Lin; Man Zhang; Xiaomeng Ma; Yingying Liu; Zhanhang Wang; Yuefeng Zhang; Zuying Kuang; Zhiwei Lu; Xuefei Li; Lili Ma; Xiuli Lin; Lei Si; Xiaohong Chen
Journal:  Cell Death Discov       Date:  2020-08-11

Review 2.  Defining Dysbiosis in Disorders of Movement and Motivation.

Authors:  Christopher T Fields; Timothy R Sampson; Annadora J Bruce-Keller; Drew D Kiraly; Elaine Y Hsiao; Geert J de Vries
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

Review 3.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

4.  Can epilepsy be treated by antibiotics?

Authors:  Hilde M H Braakman; Jakko van Ingen
Journal:  J Neurol       Date:  2018-06-21       Impact factor: 4.849

5.  An infection of Enterobacter ludwigii affects development and causes age-dependent neurodegeneration in Drosophila melanogaster.

Authors:  Subhashree Priyadarsini; Moumita Sahoo; Swetapadma Sahu; Rasu Jayabalan; Monalisa Mishra
Journal:  Invert Neurosci       Date:  2019-10-22

Review 6.  The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings.

Authors:  Helen Tremlett; Emmanuelle Waubant
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

7.  A gut feeling about multiple sclerosis.

Authors:  Francisco J Quintana; Marco Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 8.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

9.  Quantifying muscle alterations in a Parkinson's disease animal model using electromyographic biomarkers.

Authors:  Pablo Y Teruya; Fernando D Farfán; Álvaro G Pizá; Jorge H Soletta; Facundo A Lucianna; Ana L Albarracín
Journal:  Med Biol Eng Comput       Date:  2021-07-23       Impact factor: 2.602

10.  Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis.

Authors:  Kathryn C Fitzgerald; Diane Vizthum; Bobbie Henry-Barron; Amy Schweitzer; Sandra D Cassard; Eric Kossoff; Adam L Hartman; Dimitrios Kapogiannis; Patrick Sullivan; David J Baer; Mark P Mattson; Lawrence J Appel; Ellen M Mowry
Journal:  Mult Scler Relat Disord       Date:  2018-05-05       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.